"Long term Outcomes of NRG Oncology/RTOG 0529: A Phase II Evaluation of" by Andre Abitbol

Skip to main content

All Publications

Authors

Andre Abitbol, Miami Cancer InstituteFollow

Title

Long term Outcomes of NRG Oncology/RTOG 0529: A Phase II Evaluation of Dose-Painted Intensity Modulated Radiation Therapy (DP-IMRT) in Combination with 5-Fluorouracil and Mitomycin-C for the Reduction of Acute Morbidity in Anal Canal Cancer

Publication Date

1-1-2022

Content Type

Article

PubMed ID:

Additional Authors:

Additional authors and institutional affiliations

Citation

International Journal of Radiation Oncology, Biology, Physics (2022) 112(1):146-157

Restricted

Available to BHSF community via local IP address or BHSF login.

Find in your library

COinS